Development of a high-performance liquid chromatography method for simultaneous determination of pioglitazone and felodipine in pig serum: Application to pharmacokinetic study

Biomedical Chromatography

Volumn 25, Issue 8, 2011, Pages 952-958

  Palem, Chinna Reddy ^a   Gannu, Ramesh ^a   Yamsani, Shravan Kumar ^a   Yamsani, Vamshi Vishnu ^a   Yamsani, Madhusudan Rao ^a  

^a KAKATIYA UNIVERSITY   (India)

Author keywords

Felodipine; Pharmacokinetics; Pig serum; Pioglitazone; Reversed phase high performance liquid chromatography

Indexed keywords

BODY FLUIDS; CHROMATOGRAPHIC ANALYSIS; DICHLOROMETHANE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; MAMMALS; PRECIPITATION (CHEMICAL); PYRIDINE;

ANALYTES; FELODIPINE; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; NITRENDIPINE; PHARMACOKINETIC STUDIES; PIG SERUM; PIOGLITAZONE; REVERSED-PHASE HIGH PERFORMANCE; REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; SIMULTANEOUS DETERMINATIONS;

PHARMACOKINETICS;

ACETONITRILE; AMMONIUM ACETATE; DICHLOROMETHANE; FELODIPINE; NITRENDIPINE; PIOGLITAZONE;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; EXPERIMENTAL PIG; LIMIT OF DETECTION; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRECIPITATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TABLET FORMULATION; TIME TO MAXIMUM PLASMA CONCENTRATION;

SUIDAE;

EID: 79959950540     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1553     Document Type: Article

References (22)

1. Ahnoff M. Determination of felodipine in plasma by gas chromatography with electron capture detection. Journal of Pharmaceutical Biomedical Analysis 1984; 2: 519-526.
2. Ahnoff M, Ervik M and Johnsson L. Comparison of high-selectivity gas chromatographic methods, including column switching, for the determination of felodipine in plasma. Journal of Chromatography 1987; 394: 419-427.
3. Dru JDY, Hsieh JYK, Matuszewski BK and Dobrinska MR. Determination of felodipine, its enantiomers, and a pyridine metabolite in human plasma by capillary gas chromatography with mass spectrometric detection. Journal of Chromatography B 1995; 666: 259-267.
4. Eckland DA and Danhof M. Clinical pharmacokinetics of pioglitazone. Experimental and Clinical Endocrinology and Diabetes 2000; 108: 234-242.
5. Edgar B, Collste P, Haglund, K and Regardh CG. Pharmacokinetics and haemodynamic effects of felodipine as monotherapy in hypertensive patients. Clinical Investigative Medicine 1987; 10: 388-394.
6. Fahim A, Nereida KCL and Gerald MR. Relationship between changes in insulin sensitivity and associated cardiovascular disease risk factors in thiazolidinedione treated, insulin resistant, non diabetic individuals: pioglitazone versus rosiglitazone. Metabolism 2009; 58: 373-378.
7. Gabrielsson M, Hoffmann KJ and Regaerdh CG. Determination of four carboxylic acid metabolites of felodipine in plasma by high-performance liquid chromatography. Journal of Chromatography: Biomedical Applications 1992; 111: 265-274.
8. FDA. Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research: Rockville, MD, 2001.
9. Henig K and Bucheli F. Application of column-switching liquid chromatography-tandem mass spectrometry for the determination of pharmaceutical compounds in tissue samples. Journal of Chromatography B: Analytical Technology in Biomedical Life Sciences 2002; 769: 9-26.
10. Karavas E, Ktistis G, Xenakis A and Georgarakis E. Miscibility behaviour and formation mechanism of stabilized felodipine-polivinylpyrrolidone amorphous nanodispersions. Drug Development and Industrial Pharmacy 2005; 31: 473-489.
11. Lesh CA, Squier CA, Cruichley DM and Williams PS. The permeability of human oral mucosa and skin to water. Journal of Dental Research 1989; 68: 1345-1349.
12. Lindmark B, Ahnoff M and Persson B. Enantioselective determination of felodipine in human plasma by chiral normal-phase liquid chromatography and electrospray ionisation mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2002; 27: 489-495.
13. Lopez JA, Martinez V, Alonso RM and Jiminez RM. High-performance liquid chromatography with amperometric detection applied to the screening of 1, 4-dihydropyridines in human plasma. Journal of Chromatography A 2000; 870: 105-114.
14. Lotfy Saber AMR. Determination of pioglitazone hydrochloride in tablets by high-performance liquid chromatography. Pakistan Journal of Analytical and Environmental Chemistry 2008; 9: 118-121.
15. Migliorança LH, Barrientos-Astigarraga RE, Schug BS, Blume HH, Pereira AS and Nucci AD. Felodipine quantification in human plasma by high-performance liquid chromatography coupled to tandem mass spectrometry. Journal of Chromatography B 2005; 814: 217-223.
16. Mostafa GA and Al-Majed A. Characteristics of new composite- and classical potentiometric sensors for the determination of pioglitazone in some pharmaceutical formulations. Journal of Pharmaceutical and Biomedical Analysis 2008; 48: 57-61.
17. Nishioka R, Umeda I, Oi N, Tabata S and Uno K. Determination of felodipine and its metabolites in plasma using capillary gas chromatography with electron-capture detection and their identification by gas chromatography-mass spectrometry. Journal of Chromatography 1991; 565: 237-246.
18. Physician's Desk Reference. Medical Economics Company: Montivale, NJ, 2000; 54: 3088-3094.
19. Radhakrishna T, Sreenivas Rao D and Om Reddy G. Determination of pioglitazone hydrochloride in bulk and pharmaceutical formulations by HPLC and MEKC methods. Journal of Pharmaceutical and Biomedical Analysis 2002; 29: 593-607.
20. Soons PA, Roosemalen MCM and Breimer DD. Enantioselective determination of felodipine and other chiral dihydropyridine calcium entry blockers in human plasma. Journal of Chromatography: Biomedical Applications 1990; 93: 343-356.
21. Vamshi VY, Chandrasekhar K, Ramesh G and Madhusudan Rao Y. Development of mucoadhesive patches for buccal administration of carvedilol. Current Drug Development 2007; 4: 27-39.
22. Xue YJ, Turner KC, Meeker JB, Pursley J, Arnold M and Unger S. Quantitative determination of pioglitazone in human serum by direct-injection high-performance liquid chromatography mass spectrometry and its application to a bioequivalence study. Journal of Chromatography B 2003; 795: 215-226.